SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
LigoCyte Awarded An Additional $2.3M Department Of Defense Contract To Continue The Preclinical Development Of Their 3rd Generation, Mucosal Anthrax Vaccine